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Abstract: Solidago chilensis Meyen (Asteraceae) is a medicinal and aromatic herb widely distributed in South America. From 2000 to the 
present numerous articles on this species have been published, mainly in the last decade where the pharmacological studies and articles on 
its secondary metabolites have risen sharply. S. chilensis has potential beneficial effects on human health, particularly as an anti-
inflammatory because of its high flavonoid content. This work describes the research carried out on this species with emphasis on biological 
and phytochemical studies.. 
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Resumen: Solidago chilensis Meyen (Asteraceae) es una hierba aromática y medicinal, ampliamente difundida en Sudamérica. A partir del 
año 2000 se publicaron numerosos estudios sobre esta planta, particularmente en la última década donde se incrementó sensiblemente el 
estudio de sus propiedades farmacológicas y de la química de sus metabolitos secundarios. Es una planta con propiedades potencialmente 
beneficiosas para la salud humana, destacándose particularmente por su actividad antiinflamatoria que puede ser atribuida al elevado 
contenido en flavonoides. En este trabajo revisamos exhaustivamente los antecedentes de esta planta desde un enfoque cronológico, con 
énfasis en los estudios biológicos y fitoquímicos. 
 
Palabras clave: Solidago chilensis, Solidago microglosa, actividad antioxidante, actividad antiinflamatoria, solidagenona, quercetina, 
quercetrina.. 
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INTRODUCTION 
Initials considerations 
An exhaustive chronological review on Solidago 
chilensis Meyen (Asteraceae) with emphasis on the 
biological studies and its secondary metabolites 
chemistry is presented.  
Interest on this species is booming. Figure 
1 shows the cumulative number of publications for 
S. chilensis in the period 1970-2017. The number of 
publications has skyrocketed in the last decade 
(2007-2017). 
 
Figure 1 
Cumulative number of citations on S. chilensis. The first report on a relevant topic is marked with a 
letter: a) Distribution in South American Ecosystems in 1973 b) Phytochemical, flavonoids identification 
in 1981 c) Antimicrobial bioassay in 2002 d) Pharmacological study with an animal model in 2002 e) 
Clinical trial in 2010. 
 
S. chilensis is a very promising species. 
Due to its wide range of distribution covering 
different ecosystems of South America, 
comparative phytochemical and biological studies 
on plants collected at different sites are needed to 
detect intraspecific variations (chemotypes). 
Studies are also needed to know seasonal variations 
and changes associated with the growth phase of 
the plant. 
Valverde et al. (2012) emphasize the 
importance of this medicinal plant in Brazil where 
it is being widely used by people and companies 
(private and public). In 2010 the Brazilian Ministry 
of Health considered S. chilensis as a plant with 
potential to generate products of pharmaceutical 
interest for the Brazilian Unified Health System. 
Currently this species is under cultivation in the 
Agroecological Platform of Phytomedicines (PAF) 
at Campus Fiocruz Atlantic Forest (CFMA)-Río de 
Janeiro. 
General description and distribution 
Solidago chilensis Meyen (Asteraceae) is a native 
species to South America that grows between 0 and 
2500 meters above sea level. It is an herbaceous 
plant with abundant rhizomes that can reach up to 
1.4 meters in height. It has an erect and leafy stem, 
the flowers arrangement is a typical dense 
pyramidal inflorescence. Figure 2 shows a 
representative picture of this plant. The first report 
and description of this plant was made by F. Meyen 
(1834) and in Argentina by Spegazzini (1897) 
under the synonymy S. linearifolia var. 
brachypoda.  
A recent anatomical study was done by 
Hernandez et al. (2013) who noted epidermal 
characteristics of a xerophile species; also 
identified essential oils reservoirs in different 
organs of the plant. The chromosome composition 
for S. chilensis is 2n = 2x = 18 (Dematteis et al., 
2007; Laphitz & Semple, 2015; Semple, 2016).  
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According to Catalog of vascular plants of 
South Cone (http://www.darwin.edu.ar) and Correa 
(1971), in Argentina this plant occurs in Buenos 
Aires, Catamarca, Chaco, Chubut, Cordoba, 
Corrientes, Entre Ríos, Formosa, Jujuy, La Pampa, 
La Rioja and Mendoza provinces. In Brazil it is 
mainly found in the states of Rio Grande Do Sul 
and Santa Catarina. In Chile it grows in Region I, 
Region III, Region IV, Region V, Region VI, 
Region VII, Region VIII, Region IX, Region X, 
Region XI, Juan Fernández archipelago and 
Metropolitan Santiago Region. In Paraguay it is 
found in Alto Paraguay and Cordillera. In Uruguay 
its presence has been reported in Montevideo, 
Paysandú and Soriano.  
Laphitz & Semple (2015) made up a map 
of the current distribution of S. chilensis, although 
we consider the actual distribution is wider, since 
the species is found also in Brazil (Valverde et al., 
2012). In Figure 3 we propose an updated map of S. 
chilensis distribution in South America. In addition 
Silva et al. (2008) recorded S. chilensis in the 
Madeira Islands of Portugal, where it could have 
arrived by sea.  
 
Figure 2  
S. chilensis photography 
 
Synonyms and common names 
Synonyms 
According to Catalog of vascular plants of South 
Cone (http://www.darwin.edu.ar) and The Plan List 
 
(http://www.theplantlist.org), the main accepted 
synonyms are: Solidago linearifolia DC., Solidago 
microglossa DC. Other synonyms registered in 
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these databases are: Aster sagei Phil., Solidago 
coquimbana Phil., Solidago floribunda Phil., 
Solidago laxiflora Phil., Solidago parviflora Phil., 
Solidago recta Phil., Solidago valdiviana Phil. In 
addition Russo & Garbarino (2008) quotes the 
following: Solidago polyglossa DC., Solidago 
marginella DC., Solidago odora Hook., Solidado 
vulneraria Mart., Solidago nitidula Mart.  
It should be noted that Laphiz (2009) and 
Laphiz & Semple (2015) consider that S. chilensis 
and S. microglossa are different species with 
different anatomical characteristics (stem hair 
length). However, in South America both species 
have the same popular use and a similar 
phytochemical profile. The morphological 
differences of S. microglossa could be attributed to 
a morphotype adapted to the environmental 
conditions of the northern populations. It would be 
very useful to perform chemotaxonomic and 
molecular analysis to confirm whether we are 
dealing with a single species or not, as well as if 
there exist variations in the phytochemical profile 
among populations of different habitats. 
At this point it should be noted that S. 
microglossa is the only synonym that remains in 
use in current literature. So, and according to 
Mercandeli et al. (2012), in pharmacognosy and 
related areas it could be considered as a species 
with two accepted names: S. chilensis and S. 
microglossa.  
 
 
Figure 3 
Distribution for S. chilensis in South America 
Common names 
“Golden rod” is the most used common name of 
this plant and for members of genus Solidago in 
general. Other common names in Argentina and 
Chile are "vara amarilla" (yellow stick), "lanceta" 
(lancet), "punta de lanza" (spearhead), "romerillo 
amarillo" (yellow romerillo), (Alonso & 
Desmachelier, 2005). Mapuche names in Argentina 
and Chile: pfelel, felel (González & Molares, 
2004). Brazilian common names: arnica, arnica-
brasileira, arnicahorta, arnica-de-terreiro, arnica-
brasil, arnica-silvestre, erva-federal, erva-lanceta, 
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espiga-ouro, federal, flecha, lanceta, macela-
miu´da, rabo-de-foguete, rabo-de-roja˜o, sape´-
macho (Alonso & Desmachelier, 2005; Russo & 
Garbarino, 2008). Guaraní names in Paraguay: 
mbuí, mbuí saiyu, mberí ivotí, mbuychi, mbuí 
guazú and cohete ruguai. (Marzocca, 1997; Alonso 
& Desmachelier, 2005; Russo & Garbarino, 2008).  
 
ETHNOMEDICINAL USES 
S. chilensis has variety of uses in the countries 
where it is present. According to Ferrari et al. 
(2014) and Mercandeli et al. (2012), the plant is 
used for numerous purposes and conditions. 
Ethnopharmacological uses are mostly related to 
inflammatory conditions and can be explained by 
the high contents of flavonoids in the plant. 
 
Argentina 
Argentinean literature cites it has been used as 
vulnerary, anti-gonorrhea and because of its 
revulsive properties. The root has been used as a 
sedative and for headaches, in addition to being 
used as baths for children with nervous problems. 
(Toursarkissian, 1980; Marzocca, 1997; Nuñez & 
Cantero, 2000).  
Alonso & Desmachelier (2005) state S. 
chilensis has similar uses to S. virgaurea, a species 
widely known in Europe and Japan. The most 
common use is as infusion or decoction of aerial 
parts or roots. These authors report its use as 
sedative, diuretic, anti-inflammatory and for wound 
healing. Forcone (2004) also mentions it is used as 
a therapeutic agent for renal and urinary 
inflammations. 
  
Brazil 
In Brazilian popular medicine, it is recommended 
as a diuretic, analgesic and anti-inflammatory to 
treat burns and rheumatic disease, among others 
(Goulard et al., 2007; Liz et al., 2008). It is 
observed that most common use in folk medicine is 
related to inflammatory conditions, being used in 
the reduction of pain and edema, characteristic 
symptoms of inflammation (Valverde et al., 2012). 
Mercandeli et al. (2012) indicated that this plant 
have antiseptic, analgesic, and healing properties. 
Other uses include treating rheumatic and lumbar 
pain, contusions, wounds, and inflammations 
caused by insect bites. Also it is used as a 
gastrointestinal stimulant, healing and antiseptic. 
 
Chile 
The plant is used to treat symptomatology related to 
inflammation (Schmeda-Hirschmann et al., 2002). 
 
Paraguay 
Degen et al. (2005) indicate the plant has been used 
for kidney diseases. 
 
Uruguay 
The infusion of S. chilensis has been reported as 
antilithic, since it is used preventively and as a 
therapeutic agent for renal and urinary 
inflammations (Güntner et al., 1999). The study of 
the RI index (Relative Importance) made by Ferrari 
et al. (2014) in an ethnobotanic survey, reported a 
RI = 100% for S. chilensis, which means that the 
plant is used for numerous purposes and conditions. 
 
PHYTOCHEMISTRY 
The most relevant compounds isolated from S. 
chilensis are shown in Figure 4. 
 
Phenolic compounds and antioxidant activity 
In 1981 appeard in Buenos Aires-Argentina the 
first report on phenolic compounds from aerial 
parts of S. chilensis where several flavonoids were 
isolated and identified: isorhamnetin, quercetin 3-
O-rhamnoside, quercetin 3-O-galactoside, and 
rutin. (Gutierrez et al., 1981). Günter et al. (1999) 
from plants collected at Montevideo-Uruguay, 
reported that the inflorescences are a source of free 
and glycosidic flavonoids derived from kaempferol, 
quercetin and others. In the same work, the 
antioxidant properties of different flower extracts 
and fractions containing flavonoids were studied. 
The total antioxidant capacity of the extracts was 
monitored spectrophotometrically measuring the 
color loss of solutions of -carotene in presence of 
0.1% hydrogen peroxide. The most effective 
fraction was composed of 50% quercetin which has 
more effective antioxidant activity than butylated 
hydroxytoluene (BHT), a food industry synthetic 
antioxidant. Russo and Garbarino (2008) indicated 
that S. chilensis showed antioxidant activity similar 
to other Solidago species. 
Tamura et al. (2009) investigated the main 
components of a hydroalcoholic extract (93% 
ethanol) from aerial parts of plants collected in São 
Paulo-Brazil. The extract was analyzed using high 
pressure liquid chromatography coupled to a diode 
detector and a mass spectrometer (HPLC–DAD–
MS). The major components of the extract were 
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rutin and two caffeoylquinic acid derivatives. 
From an ethanol extract Sabir et al. (2012) 
in Santa María-Brazil reported the following values 
in terms of  milligrams of compound per gram of 
freeze-dried extract (mg/g): total phenolics (226 
mg/g), total flavonoids (115.2 mg/g), quercetrin 
(quercetin-3-O-α-L-rhamnoside) (51.9 mg/g), gallic 
acid (24.1 mg/g), rutin (3.82 mg/g), quercetin (2.57 
mg/g). The extract showed high antioxidant 
activity. In a similar approach, from an aqueous 
extract of leaves, Löbler et al. (2013) also in Santa 
María-Brazil, identified and quantified: quercetin 
(441.4 mg/g), chlorogenic acid (95.7 mg/ g) and 
rutin (46.9 mg/g). 
Roman et al. (2015) from Chapecó-Brazil, 
using HPLC with the internal standard method, 
identified quercetrin as the main flavonoid in 
hydroalcoholic extracts. The amount of quercetrin 
was 0.2916 g of quercetrin/g of total extract, so 
they concluded that aerial parts of S. chilensis 
contain 6.5% of quercetrin. In similar works, 
Schneider et al. (2015) and Vechia et al. (2016) 
found, respectively, 2.4% and 5.29% of quercetrin 
in the aerial parts, and the amount of quercetrin is 
proposed as a quality control marker of the plant 
drug. Barros et al. (2016) also reported quercitrin 
for a Santa Catarina-Brazil collection, where the 
flavonoid azeliny was also identified. 
Gastaldi et al. (2016a) in Esquel-Argentina 
with a dietary approach found the following values 
for one infusion cup (250 ml) prepared from 5.0 g 
of air dried aerial parts (flowers, leaves and stems): 
antioxidant capacity equivalent to 192 mg of 
ascorbic acid (Vitamin C); a total phenol content 
equivalent to 93 mg of gallic acid and a total 
flavonoid content equivalent to 69 mg of quercetin. 
 
Terpenes 
The first report on terpenoids was in 1980 that 
showed dihydroxycarotenoids as the main 
carotenoids of S. chilensis (Caffini et al., 1980).  
From the roots of populations from Buenos 
Aires-Argentina, two well-known furan diterpenes 
were isolated by Gutierrez et al. (1981): junceic 
acid and solidagenone. Solidagenone, a highly 
bioactive molecule, was also isolated from plants 
collected in Asunción-Paraguay (Schmeda-
Hirschmann, 1988) and tested in mice.  
Composition of the essential oil from aerial 
parts has been analyzed by gas chromatography-
flame ionization detector-mass spectrometry (GC-
FID-MS) in two Argentina populations: one from 
Santa Fe province (Vila et al., 2002) and the other 
from Chubut province (Gonzalez et al., 2013; 
Gastaldi et al., 2016b). In the essential oil from the 
Santa Fe collection, pumiloxide, an unusual 
labdane diterpene, was found to be one of the major 
components, up to 15.3%; other important 
components were limonene 15,4%, caryophyllene 
oxide 3,5%, β-elemene 3,4%,  γ-cadinene 8,2%, 
and germacrene D 3,1%. The composition of the 
essential oil of the population from Chubut was 
analyzed during four years; the main identified 
components being myrcene 8,2%, alfa-phellandrene 
13,1 %, limonene 46,6 % and germacrene D 43%. 
A high content of limonene and germacrene D was 
found in both populations from Argentina. 
 
Other compounds 
Gutierrez et al. (1981) reported the presence of 
hydrocarbons in flowers and leaves. The flowers 
have hydrocarbons of 22 to 35 carbons, mostly C29 
10,46%, C31 52,19%, C32 5,50%, C33 18,74% and 
C35 4,17%. The leaves have hydrocarbons of 17 to 
37 carbons, mostly C31 69,04%, C32 3,88% and C34 
7,31%.  
Using histochemical methods Hernandez et 
al. (2013) identified inulin, lipophilic substances 
and starch.  
The seasonal variation of saponins in plants 
collected in Beriso, Buenos Aires, Argentina was 
studied by Arrambarri & Hernandez (2014). The 
saponins content was determined by the height of 
the foam formed. Saponins were always present in 
underground organs (roots and rhizomes), but 
leaves collected at the end of summer and early 
autumn (March-April) also gave a highly positive 
reaction. Accordingly, March and April are the 
most suitable months to extract saponins from S. 
chilensis under natural conditions. 
 
BIOACTIVITY 
Cell assays 
Razmilic & Schmeda (2000) studied the 
cytotoxicity of diterpene solidagenone and four 
semi-synthetic derivatives in L 1210, BHK and 
COS 7 cell lines that exhibited inhibitory 
concentrations 50 (IC50) between 10-100 μg/ml. 
They also studied possible mechanisms of anti-
inflammatory activity on glucocorticoid-mediated 
signal transduction and found activities between 1-
25 μg/ml. 
Bagatini et al. (2009) using the Allium cepa 
test showed that infusions of this plant have 
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cytotoxic but not mutagenic effect.  They showed 
the existence of antiproliferative and cytotoxic 
activities suggesting a possible therapeutic potential 
to inhibit the cell cycle in eukaryotic organisms. 
Accordingly, Gastaldi et al. (2016a) investigated 
the antiproliferative effect of the infusion on colon 
cancer cell line T84, finding an effective 
concentration 50 (EC50) of 0.16 mg/ml; this is a 
promising result suggesting that this plant has 
potential to inhibit the proliferation of colon cancer 
cells. 
Freitas et al. (2008) analyzed the effect of 
aqueous extracts on the osmotic stability of human 
erythrocytes. In this assay the extract displayed 
simultaneously hemolytic and anti-hemolytic 
effects. The hemolytic activity may be related to 
the presence of saponins that form complexes with 
sterols, proteins and phospholipids, thereby 
modifying membrane permeability. The 
antagonistic anti-haemolytic activity may be related 
to flavonoids that can be incorporated into 
erythrocyte membranes. The presence of these 
antagonistic effects reflects the heterogeneous 
nature of the extract and indicates a need to 
fractionate it to characterize the components 
responsible for each effect. 
Gastaldo et al. (2012) reported that a water-
ethanol extract increases the release of cytokines in 
human cultured cells. It should be noted that this 
reference presents highly summarized information 
without in-depth analysis. 
 
Figure 4 
Some relevant compounds isolated from S. chilensis. Flavonoids: a) quercetrin (= quercetin-3-O--L-
rhamnoside); b) quercetin; c) rutin. Terpenoids: d) pumiloxide; e) solidagenone; f) limonene; g) 
germacrene D; h) γ-cadinene. 
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Antimicrobial and antifungal activity 
Vila et al. (2002) showed that the essential oil from 
leaves of S. chilensis is an efficient antifungal 
against the dermatophyte fungi Microsporum 
gypseum and Trichophyton mentagrophytes. The oil 
was more efficient than Amphotericin B and 
Nystatin whilst resulted inactive against other 
filamentous fungi such as Aspergillius fumigatus, 
Fusarium oxysporum and Penicillium 
purpurogenum. Cryptococcus neoformans was 
slightly sensitive only at the highest dose assayed 
(10 ul). 
Duarte et al. (2005) reported that the 
essential oil displayed anti Candida albicans 
activity, whereas the ethanolic extract had no effect 
on this opportunistic fungus. The concentrations 
assayed were between 0.03 and 2 mg/ml. 
Avancini et al. (2008) reported that a 10% 
decoction of aerial parts of S. chilensis was active 
against Staphylococcus aureus (Gram-positive) 
while it had no effect against Salmonella 
choleraesuis (Gram negative). A potential 
veterinary application is suggested due to the 
positive result against S. aureus, the main 
bacterium responsible for bovine mastitis.  
Morel et al. (2006) tested the essential oil 
from leaves and a methanolic extract from roots 
against Staphylococcus aureus ATCC 6538p, 
Staphylococcus epidermidis (ATCC 12228), 
Klebsiella pneumoniae (ATCC 10031), Escherichia 
coli (ATCC 25792), Salmonella setubal (ATCC 
19796), Bacillus subtilis (ATCC 6633), 
Pseudomonas aeruginosa ATCC 27853, 
Saccharomyces cerevisiae (ATCC 2601) and 
Candida albicans (ATCC 10231). The methanol 
extract showed weak activity against the tested 
microorganisms with a minimal inhibitory 
concentration (MIC) >1 mg/ml while the essential 
oil effectively inhibited the growth of all tested 
microorganisms.  
Rafael et al. (2009) determined the 
antimicrobial activity of aqueous extracts of 
rhizomes against Staphylococcus aureus (ATCC 
25922), Escherichia coli (ATCC 25923) and 
Pseudomonas aeruginosa (ATCC 27853). The 
extracts showed the following MIC values: P. 
aeruginosa 3.1 mg/ml, E. coli 6.2 mg/ml, S. aureus 
6.2 mg/ml. The positive control using gentamicin as 
reference drug presented the following MIC values: 
P. aeruginosa 0.62 ug/ml, E. coli 1.25 ug/ml, S. 
aureus 0.62 ug/ml.  
The potential use in dentistry has 
beentested by Freires et al. (2010) using the 
microdilution method. The tooth decay producing 
bacterium Streptococcus mutans (ATCC 25175) 
and Lactobacilus casei (ATCC 7469) were exposed 
to different concentrations of a commercial tincture 
of the plant. The MICs were 7.81 and 1.95 mg/ml 
respectively. These results show the potential of the 
tincture in dental clinic as an alternative and low 
cost method in the prevention of dental caries. 
 
Animal studies 
Antiulcerogenic and gastroprotective activities 
Schmeda-Hirschmann et al. (2002) studied the 
antiulcerogenic effect of diterpene solidagenone 
and some semi-synthetic derivatives in mice. They 
found that a dose of 100 mg/Kg exerted a 
significant effect, equivalent to the control drug 
lansoprazole (20 mg/Kg).  
In other work, Bucciarelli et al. (2010) 
analyzed the gastroprotective activity and acute 
toxicity of an aqueous extract in ulcerogenic 
models induced in female of albino mice. They 
studied the activity of aqueous extracts of 
inflorescences and compared it with the antiulcer 
reference drug omeprazole. The following doses of 
extract were tested: 125, 250, 400, 800, 1200 and 
2000 mg/Kg. The extract gave promising results 
regarding antiulcerogenic activity which can be 
attributed to the flavonoid content. No toxic effects 
were observed. For this reason, the authors consider 
it as a promising plant for the development of new 
antiulcerogenic agents. 
Barros et al. (2016) also studied the 
gastroprotective activity of a methanolic extract in 
doses 100-300 mg/Kg. The gastroprotective effect 
was investigated in acute gastric ulcer models and 
the antisecretory activity was assessed in vivo and 
in vitro. They concluded that S. chilensis extract 
promotes gastroprotection and gastric healing by 
diversified and complementary modes of action. 
Flavonoids, especially quercitrin and afzelin, are 
related to its antioxidant and antisecretory 
properties in parallel to its beneficial effect on the 
mucus production. In agreement with Bucciarelli et 
al. (2010), this plant is considered a possible 
natural resource in the search for antiulcer 
compounds, mainly flavonoids. 
 
Hepatotoxicity, hepatoprotection 
Neto et al. (2004) exposed a group of rats to 16.1 
mg/Kg of aqueous extract in form of daily 
intraperitoneal injections for 14 days. They report 
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the lack of significant changes in the serum levels 
of alanine aminotransferase and aspartate, 
indicating that extract was not hepatotoxic at the 
dose assayed. However, the lethal dose 50 (LD50) 
and lethal dose 100 (LD100) in rats were 54.7 and 
86.2  mg/Kg respectively, only 3.4 and 5.4 times 
higher than therapeutic dose (16.1 mg/Kg), which 
means that the extract does not have enough safety 
margin to be used to prevent intoxication.  
In a recent work, Sabir et al. (2012) 
reported a significant hepatoprotective effect of an 
ethanol extract against paracetamol induced liver 
injury (250 mg/Kg). The animals received oral 
doses of 100 or 200 mg/Kg, per day for 7 days. 
However, the authors suggest the need for more 
detailed in vivo studies to establish the safety and 
bioavailability of plant extract. 
 
Hypoglycemic and hypolipidemic activities 
Roman et al. (2015) carried out a test in order to 
analyze the hypolipidemic and antioxidant effects 
of S. chilensis hydroalcoholic extract (HAE) on 
cholesterol-fed rats. Rats treated with extract (150, 
300, and 600 mg/Kg) and quercetrin showed 
decreased serum levels of total cholesterol and 
triacylglycerides similar to control drug 
simvastatin. Moreover, treatment with HAE and 
quercetrin decreased 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) reductase activity 
(35.1% on average) and increased the amount of 
fecal cholesterol (38.2% on average). This study 
suggested that hypolipidemic effects of HAE are 
associated with it modulating the activity of HMG-
CoA reductase and its interference in the 
reabsorption and/or excretion of intestinal lipids. S. 
chilensis and quercetrin, may thus be effective as 
cholesterol-lowering agents and in preventing 
atherosclerosis. 
Schneider et al. (2015) evaluated the 
hypoglycemic and hypolipidemic effects of HAE 
from S. chilensis aerial parts in rats. The study 
showed that a glucose dose of 4 g/Kg can 
considerably increase serum glucose level which 
was mitigated by a single oral dose of HAE at 500 
mg/kg for 180 min following glucose 
administration. Rats treated with HAE (125, 250 or 
500 mg/Kg) showed decreased serum total 
cholesterol, more than glibenclamide drug at 10 
mg/Kg. They conclude that HAE of S. chilensis 
may be effective in maintaining glucose 
homeostasis by reducing serum glucose levels and 
total cholesterol. 
Anti-inflamatory activity 
Goulart et al. (2007) made the first work of 
preclinical relevance to study the anti-inflammatory 
activity. The aim was to investigate the anti-
inflammatory effect and mechanism of action of 
aqueous extracts obtained from rhizomes, leaves 
and inflorescences of S. chilensis in a mouse model 
of pleurisy induced by carrageenan. The results 
indicated that infusions at 25-50 mg/Kg inhibited 
leukocytes, neutrophils and exudation. The extracts 
also inhibited myeloperoxidase, adenosine-
deaminase, and tumours necrosis factor alpha 
(TNF-α), and induced a decrease in the nitric oxide 
and interleukin-1 beta levels. An important anti-
inflammatory effect is demonstrated, inhibiting cell 
infiltration and also decreasing pro-inflammatory 
mediators released into the site of the inflammatory 
process. Similar results have been obtained by Liz 
et al. (2008) and Gastaldo et al. (2012) using the 
mouse “air pouch” inflammation model. 
Using Wistar rats as an experimental 
model, Tamura et al. (2009) showed the anti-
inflammatory effects of alcoholic and 
hydroalcoholic extracts of aerial parts of S. 
chilensis on oedema and leukocyte trafficking. 
Their results indicated that topical (12.5 - 50 
mg/kg) or intraperitoneal (25 or 50 mg/Kg) 
administration of the extract reduced ear oedema 
formation (> 25% reduction). Intraperitoneal 
applications of 25 mg/Kg of extract inhibited the 
migration of polymorphonuclear cells into the 
inflamed cavity (about 50%). Besides, the rolling 
behaviour and adherence of circulating leukocytes 
to postcapillary venules of the mesentery network 
was diminished (50%), but the mast cell 
degranulation in the perivascular area was not 
affected. In conclusion, local and systemic anti-
inflammatory effects of the extract are 
demonstrated, and implicate the inhibition of 
leukocyte-endothelial interactions as an important 
mechanism of action. 
Assini et al. (2013) reported the anti-
inflammatory assay of formalin, based on the direct 
injection of formalin in the paws of mice. The 
aqueous extract (25, 50 and 250 mg/Kg) was 
administered by the oral route 30 minutes prior to 
behavioural test. In this test the extract produced 
significant analgesic and anti-inflammatory effects. 
 
Activity on the central nervous system  
In order to determinate possible antidepressant and 
locomotor-type activities, Assini et al. (2013) 
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performed "open field test" and "forced swimming 
test" on Swiss mice. Experiments were performed 
with doses of 25, 50 and 250 mg/Kg. Results 
indicate that aqueous extract from S. chilensis did 
not show antidepressant-type activity. A reduction 
in the locomotor activity was noted at the highest 
administered level (250 mg/Kg), suggesting an 
effect on the central nervous system, although this 
could also be due to a peripheral muscular relaxing 
effect of the extract. 
 
Burn healing  
Catarino et al. (2015) carried out a study to 
evaluate possible positive synergic effect of laser 
therapy and hydroalcoholic extract of S. chilensis as 
phytotherapeutic agent to heal experimental 
second-degree burns in Wistar rats. The application 
of an extract combined with 670 nm laser promoted 
favourable responses in tissue repair in this 
experimental model. 
 
Others  
Rafael et al. (2009) studied the in vitro antiplatelet 
effect using a turbidimetric method. In this assay, 
the platelet aggregation is induced by adenosine 
diphosphate (ADP). The aqueous extract (400 
μg/mL) of S. chilensis was effective in inhibiting 
the platelet aggregation stimulated by ADP with a 
45% of inhibition. The observed effect may have 
important benefits over atherothrombotic diseases, 
although in vivo studies should be done to 
corroborate this activity. 
Guarda et al. 2016 investigated the 
insecticide potential of S. chilensis and other 
Brazilian plants on the mosquito Aedes aegipty, 
vector of many tropical diseases. They worked with 
aqueous extract at concentrations of 125, 250, 500, 
750 and 1000 μg/ml. The percentage efficiency was 
0% for S. chilensis, so this extract does not have 
any lethal activity on A. aegipty larvae. 
 
CLINICAL TRIALS 
The first clinical trial of S. chilensis was carried out 
by Silva et al. (2010). The authors evaluated a gel 
preparation based on ethanol extract in treating 
lumbago (low back pain). The effectiveness of S. 
chilensis used externally was examined in placebo-
controlled double-blind clinical pharmacological 
studies. Two daily skin applications of a gel 
containing a 5% extract in glycol were 
administered for 15 days to ten volunteers in a 
placebo group and to an equal number in a test 
group. Statistical analyses of the results 
demonstrated a significant reduction in the 
perception of pain and a significant increase in 
flexibility of patients in the test group as compared 
with those receiving only the placebo.  
Latter, the same group demonstrated the 
effectiveness of S. chilensis fluid extract used 
externally for treating tendinitis of flexor and 
extensor tendons of wrist and hand. Results showed 
a significant reduction in the perception of pain in 
the arms in the test group, when it was compared to 
those receiving only the placebo (Silva et al., 
2015). 
 
DISCUSION AND CONCLUSIONS 
S. chilensis is an herb widely distributed in South 
America that in the last years has aroused attention 
by its varied properties and apparent low or nil 
toxicity. According to the publications analyzed in 
this review, this herb has potential as a source of 
antiulcerogenic, hypoglycemic and hypolipidemic 
compounds and to be used in the formulation of 
anti-inflammatory preparations for external use. 
Preclinical evidence (Mercandeli et al., 2012) and 
two clinical trials with preparations for external use 
(Silva et al., 2010; Silva et al., 2015) showed no 
adverse reactions or toxicity of the extracts tested.  
Due to the plethora of active metabolites 
produced by this plant (phenolic compounds, 
flavonoids, saponins, diterpenes, essential oil, etc.), 
long-term studies on pure bioactive components or 
purified and standardized fractions are required to 
establish relationships with the observed properties 
as well as possible synergistic effects. 
Interestingly, quercetin-3-O-α-L-rhamno-
side (quercetrin) -one of the main components in 
the aerial parts- is widely cited in collections from 
northern Brazil but not reported in southern 
populations, probably due to existence of different 
chemical races. On the other hand, solidagenone, an 
antiulcerogenic diterpene, is a major metabolite in 
the rhizomes and could be used for quality control 
of underground parts of the plant. Studies on 
populations from Paraguay, Uruguay, Chile and 
Bolivia are scarce or nonexistent and further 
comparative investigations to detect possible 
chemotypes in terms of phenolic profile, 
flavonoids, diterpenes, saponins and essential oil 
are needed. In addition, research on variation in the 
type and content of active metabolites according to 
the stage of development of the plant will provide 
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extremely useful information. 
Recently an experimental crop of this 
species was started in Rio de Janeiro, Brazil to 
homogenize quality and promote a sustainable 
harvesting for productive purposes without 
affecting natural populations. Initiatives of this type 
should be promoted and encouraged in order to 
protect wild genotypes of this species.  
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